{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T00:31:23Z","timestamp":1793320283446,"version":"4.5.0"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T00:00:00Z","timestamp":1740441600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000262","name":"Foundation Fighting Blindness","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000262","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019320","name":"ONL Therapeutics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019320","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001116","name":"Foundation Fighting Blindness Inc","doi-asserted-by":"publisher","award":["CD-CL-0816-0710"],"award-info":[{"award-number":["CD-CL-0816-0710"]}],"id":[{"id":"10.13039\/100001116","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajo.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.ajo.2025.02.018","type":"journal-article","created":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T02:50:01Z","timestamp":1740538201000},"page":"149-162","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["The 1-Step Versus 2-Step Subretinal Injection Trial (1,2-SIT)\u2014A Randomized Controlled Trial to Compare Drug Reflux Following Subretinal Injection"],"prefix":"10.1016","volume":"274","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0596-1356","authenticated-orcid":false,"given":"Matthew P.","family":"Simunovic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zak J.","family":"Prime","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rhuen Chiou","family":"Chow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily Han","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeid","family":"Madanat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Perach","family":"Osaadon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tun Hang","family":"Yeo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khin Thida","family":"Oo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lay Khoon","family":"Too","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ajo.2025.02.018_bib0001","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1001\/jamaophthalmol.2016.5630","article-title":"Structural and functional recovery following limited iatrogenic macular detachment for retinal gene therapy","volume":"135","author":"Simunovic","year":"2017","journal-title":"JAMA Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajo.2025.02.018_bib0002","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1097\/IAE.0000000000002800","article-title":"Sodium fluorescein as an optical label to evaluate subretinal injection","volume":"43","author":"Simunovic","year":"2023","journal-title":"Retina"},{"issue":"6","key":"10.1016\/j.ajo.2025.02.018_bib0003","doi-asserted-by":"crossref","first-page":"2662","DOI":"10.1167\/iovs.05-1019","article-title":"A study of retinal penetration of intravitreal tenecteplase in pigs","volume":"47","author":"Kwan","year":"2006","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"10.1016\/j.ajo.2025.02.018_bib0004","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1038\/s41467-020-15317-6","article-title":"Optogenetic restoration of retinal ganglion cell activity in the living primate","volume":"11","author":"McGregor","year":"2020","journal-title":"Nat Commun"},{"issue":"10097","key":"10.1016\/j.ajo.2025.02.018_bib0005","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S0140-6736(17)31868-8","article-title":"Efficacy and safety of voretigene neparvovec (AAV2-hRPE65v2) in patients with RPE65-mediated inherited retinal dystrophy: a randomised, controlled, open-label, phase 3 trial","volume":"390","author":"Russell","year":"2017","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.ajo.2025.02.018_bib0006","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.survophthal.2015.04.004","article-title":"Submacular hemorrhage in neovascular age-related macular degeneration: a synthesis of the literature","volume":"61","author":"Stanescu-Segall","year":"2016","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.ajo.2025.02.018_bib0007","series-title":"RPE65-Related Leber Congenital Amaurosis\/Early-Onset Severe Retinal Dystrophy","author":"Chao","year":"2019"},{"issue":"20","key":"10.1016\/j.ajo.2025.02.018_bib0008","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1056\/NEJMc1509501","article-title":"Visual acuity after retinal gene therapy for choroideremia","volume":"374","author":"Edwards","year":"2016","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.ajo.2025.02.018_bib0009","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2021-049976","article-title":"Two-step versus 1-step subretinal injection to compare subretinal drug delivery: a randomised study protocol","volume":"11","author":"Simunovic","year":"2021","journal-title":"BMJ Open"},{"issue":"2","key":"10.1016\/j.ajo.2025.02.018_bib0010","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1167\/tvst.7.2.19","article-title":"Volumetric measurement of subretinal blebs using microscope-integrated optical coherence tomography","volume":"7","author":"Hsu","year":"2018","journal-title":"Transl Vis Sci Technol"},{"issue":"3","key":"10.1016\/j.ajo.2025.02.018_bib0011","doi-asserted-by":"crossref","DOI":"10.1016\/j.xops.2021.100050","article-title":"An optimized treatment protocol for subretinal injections limits intravitreal vector distribution","volume":"1","author":"Reichel","year":"2021","journal-title":"Ophthalmol Sci"},{"issue":"8","key":"10.1016\/j.ajo.2025.02.018_bib0012","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1002\/sctm.18-0210","article-title":"Optimizing donor cellular dissociation and subretinal injection parameters for stem cell-based treatments","volume":"8","author":"Scruggs","year":"2019","journal-title":"Stem Cells Transl Med"},{"issue":"9","key":"10.1016\/j.ajo.2025.02.018_bib0013","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1038\/eye.2017.158","article-title":"Technique of retinal gene therapy: delivery of viral vector into the subretinal space","volume":"31","author":"Xue","year":"2017","journal-title":"Eye (Lond)"},{"issue":"12","key":"10.1016\/j.ajo.2025.02.018_bib0014","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0209996","article-title":"The influence of subretinal injection pressure on the microstructure of the monkey retina","volume":"13","author":"Takahashi","year":"2018","journal-title":"PLoS One"},{"issue":"suppl 1","key":"10.1016\/j.ajo.2025.02.018_bib0015","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1097\/IAE.0000000000002609","article-title":"Surgical technique for subretinal gene therapy in humans with inherited retinal degeneration","volume":"39","author":"Davis","year":"2019","journal-title":"Retina"},{"issue":"6","key":"10.1016\/j.ajo.2025.02.018_bib0016","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1097\/IAE.0000000000001349","article-title":"Fluorescein-assisted subretinal tissue plasminogen activator (tPA) delivery for submacular hemorrhage","volume":"37","author":"Khan","year":"2017","journal-title":"Retina"},{"issue":"3","key":"10.1016\/j.ajo.2025.02.018_bib0017","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1097\/00006982-199616030-00001","article-title":"Natural history of subfoveal subretinal hemorrhage in age-related macular degeneration","volume":"16","author":"Avery","year":"1996","journal-title":"Retina"},{"issue":"9","key":"10.1016\/j.ajo.2025.02.018_bib0018","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/j.ophtha.2023.04.014","article-title":"Surgery, tissue plasminogen activator, antiangiogenic agents, and age-related macular degeneration study: a randomized controlled trial for submacular hemorrhage secondary to age-related macular degeneration","volume":"130","author":"Gabrielle","year":"2023","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2025.02.018_bib0019","doi-asserted-by":"crossref","first-page":"3649","DOI":"10.2147\/OPTH.S324091","article-title":"Subretinal injection of recombinant tissue plasminogen activator and gas tamponade to displace acute submacular haemorrhages secondary to age-related macular degeneration","volume":"15","author":"Iannetta","year":"2021","journal-title":"Clin Ophthalmol"},{"issue":"7","key":"10.1016\/j.ajo.2025.02.018_bib0020","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1038\/eye.2016.65","article-title":"Vitrectomy with subretinal tissue plasminogen activator and ranibizumab for submacular haemorrhages secondary to age-related macular degeneration: retrospective case series of 45 consecutive cases","volume":"30","author":"Gonzalez-Lopez","year":"2016","journal-title":"Eye (Lond)"},{"issue":"3","key":"10.1016\/j.ajo.2025.02.018_bib0021","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.jcjo.2013.01.023","article-title":"Anti-VEGF response in macular hemorrhage and incidence of retinal pigment epithelial tears","volume":"48","author":"Varshney","year":"2013","journal-title":"Can J Ophthalmol"},{"issue":"2","key":"10.1016\/j.ajo.2025.02.018_bib0022","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.ophtha.2014.08.020","article-title":"Outcomes of eyes with lesions composed of >50% blood in the comparison of age-related macular degeneration treatments trials (CATT)","volume":"122","author":"Altaweel","year":"2015","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.ajo.2025.02.018_bib0023","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0002-9394(14)75575-8","article-title":"Factors prognostic of visual outcome in patients with subretinal hemorrhage","volume":"109","author":"Bennett","year":"1990","journal-title":"Am J Ophthalmol"},{"issue":"6","key":"10.1016\/j.ajo.2025.02.018_bib0024","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/0002-9394(82)90301-4","article-title":"Experimental subretinal hemorrhage in rabbits","volume":"94","author":"Glatt","year":"1982","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2025.02.018_bib0025","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1097\/IAE.0000000000004296","article-title":"The fight inherited retinal blindness! project: a new treatment outcome and natural history registry for inherited retinal disease","volume":"45","author":"Simunovic","year":"2025","journal-title":"Retina"},{"issue":"3","key":"10.1016\/j.ajo.2025.02.018_bib0026","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1167\/iovs.05-0981","article-title":"Visual acuities \"hand motion\" and \"counting fingers\" can be quantified with the Freiburg visual acuity test","volume":"47","author":"Schulze-Bonsel","year":"2006","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2","key":"10.1016\/j.ajo.2025.02.018_bib0027","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0002-9394(14)72259-7","article-title":"Tissue plasminogen activator treatment of experimental subretinal hemorrhage","volume":"111","author":"Lewis","year":"1991","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajo.2025.02.018_bib0028","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/0165-3806(83)90211-0","article-title":"Effect of sodium fluorescein on neurite outgrowth from the retinal explant culture: an in vitro model for retinal toxicity","volume":"313","author":"Kato","year":"1983","journal-title":"Brain Res"},{"issue":"4","key":"10.1016\/j.ajo.2025.02.018_bib0029","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1167\/tvst.6.4.4","article-title":"Impact of vital dyes on cell viability and transduction efficiency of AAV vectors used in retinal gene therapy surgery: an in vitro and in vivo analysis","volume":"6","author":"Salvetti","year":"2017","journal-title":"Transl Vis Sci Technol"},{"issue":"3","key":"10.1016\/j.ajo.2025.02.018_bib0030","first-page":"864","article-title":"In vitro characterization of a spontaneously immortalized human Muller cell line (MIO-M1)","volume":"43","author":"Limb","year":"2002","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"9","key":"10.1016\/j.ajo.2025.02.018_bib0031","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1097\/IAE.0000000000003137","article-title":"Surgical retinal explants as a source of retinal progenitor cells","volume":"41","author":"Too","year":"2021","journal-title":"Retina"},{"issue":"1","key":"10.1016\/j.ajo.2025.02.018_bib0032","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1097\/IAE.0b013e31806e60db","article-title":"A 40 degrees gaze down position for pneumatic displacement of submacular hemorrhage: clinical application and results","volume":"28","author":"Lincoff","year":"2008","journal-title":"Retina"}],"container-title":["American Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939425000777?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939425000777?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T03:55:12Z","timestamp":1777694112000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002939425000777"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":32,"alternative-id":["S0002939425000777"],"URL":"https:\/\/doi.org\/10.1016\/j.ajo.2025.02.018","relation":{},"ISSN":["0002-9394"],"issn-type":[{"value":"0002-9394","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The 1-Step Versus 2-Step Subretinal Injection Trial (1,2-SIT)\u2014A Randomized Controlled Trial to Compare Drug Reflux Following Subretinal Injection","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajo.2025.02.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2025 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}